Adamo C. M., Dai D.-F., Percival J. M., Minami E., Willis M. S., Patrucco E. and Beavo J. A. 2010 Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. USA 107, 19079–19083.

Article  PubMed  PubMed Central  Google Scholar 

Bachiller S., Alonso-Bellido I. M., Real L. M., Pérez-Villegas E. M., Venero J. L., Deierborg T. et al. 2020 The Ubiquitin Proteasome System in Neuromuscular Disorders: Moving Beyond Movement. Int. J. Mol. Sci. 21, 6429.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bassett D. I. and Currie P. D. 2003 The zebrafish as a model for muscular dystrophy and congenital myopathy. Hum. Mol. Genet. 12, R265–R270.

Article  CAS  PubMed  Google Scholar 

Bassett D. I. and Currie P. D. 2004 Identification of a zebrafish model of muscular dystrophy. Clin. Exp. Pharmacol. Physiol. 31, 537–540.

Article  CAS  PubMed  Google Scholar 

Bassett D. I., Bryson-Richardson R. J., Daggett D. F., Gautier P., Keenan D. G. and Currie P. D. 2003 Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo. Development 130, 5851–5860.

Article  CAS  PubMed  Google Scholar 

Batra A., Vohra R. S., Chrzanowski S. M., Hammers D. W., Lott D. J., Vandenborne K. et al. 2019 Effects of PDE5 inhibition on dystrophic muscle following an acute bout of downhill running and endurance training. J. Appl. Physiol. 126, 1737–1745.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berger J., Berger S., Hall T. E., Lieschke G. J. and Currie P. D. 2010 Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology. Neuromuscul. Disord. 20, 826–832.

Article  PubMed  Google Scholar 

Bies R. D., Friedman D., Roberts R., Perryman M. B. and Caskey C. T. 1992 Expression and localization of dystrophin in human cardiac Purkinje fibers. Circulation 86, 147–153.

Article  CAS  PubMed  Google Scholar 

Birnkrant D. J., Bushby K., Bann C. M., Alman B. A., Apkon S. D., Blackwell A., Ward L. M. et al. 2018 Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 17, 347–361.

Article  PubMed  PubMed Central  Google Scholar 

Brennan C. M., Emerson C. P. Jr., Owens J. and Christoforou N. 2021 p38 MAPKs - roles in skeletal muscle physiology, disease mechanisms, and as potential therapeutic targets. JCI Insight 6, e149915.

Article  PubMed  PubMed Central  Google Scholar 

Bruusgaard J. C., Liestøl K., Ekmark M., Kollstad K. and Gundersen K. 2003 Number and spatial distribution of nuclei in the muscle fibres of normal mice studied in vivo. J. Physiol. 551, 467–478.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buddhe S., Cripe L., Friedland-Little J., Kertesz N., Eghtesady P., Finder J., Hor K. et al. 2018 Cardiac management of the patient with Duchenne muscular dystrophy. Pediatrics 142, S72–S81.

Article  PubMed  Google Scholar 

Campbell C., Barohn R. J., Bertini E., Chabrol B., Comi G. P., Ryan M. M. et al. 2020 Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy. J. Comp. Eff. Res. 9, 973–984.

Article  PubMed  Google Scholar 

Campbell K. P. and Kahl S. D. 1989 Association of dystrophin and an integral membrane glycoprotein. Nature 338, 259–262.

Article  CAS  PubMed  Google Scholar 

De Luca A. 2012 Preclinical drug tests in the mdx mouse as a model of dystrophinopathies: an overview. Acta Myol. 31, 40–47.

PubMed  Google Scholar 

De Palma C., Morisi F., Cheli S., Pambianco S., Cappello V., Vezzoli M. and Clementi E. 2012 Autophagy as a new therapeutic target in Duchenne muscular dystrophy. Cell Death Dis. 3, e418.

Article  PubMed  PubMed Central  Google Scholar 

Delacroix C., Hyzewicz J., Lemaitre M., Friguet B., Li Z., Klein A. and Ferry A. 2018 Improvement of dystrophic muscle fragility by short-term voluntary exercise through activation of Calcineurin pathway in mdx mice. Am. J. Pathol. 188, 2662–2673.

Article  CAS  PubMed  Google Scholar 

Devoto S. H., Melançon E., Eisen J. S. and Westerfield M. 1996 Identification of separate slow and fast muscle precursor cells in vivo, prior to somite formation. Development 122, 3371–3380.

Article  CAS  PubMed  Google Scholar 

Doorenweerd N., Dumas E. M., Ghariq E., Schmid S., Straathof C. S., Roest A. A, et al. 2017 Decreased cerebral perfusion in Duchenne muscular dystrophy patients. Neuromuscul. Disord. 27, 29–37.

Article  PubMed  Google Scholar 

Dowling P., Murphy S. and Ohlendieck K. 2016 Proteomic profiling of muscle fibre type shifting in neuromuscular diseases. Expert Rev. Proteomics 13, 783–799.

Article  CAS  PubMed  Google Scholar 

Duan D., Goemans N., Takeda S. I., Mercuri E. and Aartsma-Rus A. 2021 Duchenne muscular dystrophy. Nat. Rev. Dis. Primers 7, 13.

Article  PubMed  PubMed Central  Google Scholar 

Ervasti J. M., Ohlendieck K., Kahl S. D., Gaver M. G. and Campbell K. P. 1990 Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345, 315–319.

Article  CAS  PubMed  Google Scholar 

Farr G. H., Morris M., Gomez A., Pham T., Kilroy E., Parker E. U. and Maves L. 2020 A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy. Skelet. Muscle 10, 29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fiacco E., Castagnetti F., Bianconi V., Madaro L., De Bardi M., Nazio F., Latella L. et al. 2016 Autophagy regulates satellite cell ability to regenerate normal and dystrophic muscles. Cell Death Differ. 23, 1839–1849.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaina G. and Popa A. 2021 Muscular dystrophy: Experimental animal models and therapeutic approaches (Review). Exp. Ther. Med. 21, 610.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Görlach A., Bertram K., Hudecova S. and Krizanova O. 2015 Calcium and ROS: A mutual interplay. Redox Biol. 6, 260–271.

Article  PubMed  PubMed Central  Google Scholar 

Grounds M. D., Radley H. G., Lynch G. S., Nagaraju K. and De Luca A. 2008 Towards developing standard operating procedures for preclinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol. Dis. 31, 1–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guyon J. R., Goswami J., Jun S. J., Thorne M., Howell M., Pusack T. and Kunkel L. M. 2009 Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin. Hum. Mol. Genet. 18, 202–211.

Article  CAS  PubMed  Google Scholar 

Guyon J. R., Mosley A. N., Zhou Y., O’Brien K. F., Sheng X., Chiang K. and Kunkel L. M. 2003 The dystrophin associated protein complex in zebrafish. Hum. Mol. Genet. 12, 601–615.

Article  CAS  PubMed  Google Scholar 

Hightower R. M., Reid A. L., Gibbs D. E., Wang Y., Widrick J. J., Kunkel L. M. and Alexander M. S. 2020 The SINE compound KPT-350 blocks dystrophic pathologies in DMD zebrafish and mice. Mol. Ther. 28, 189–201.

Article  CAS  PubMed  Google Scholar 

Hnia K., Hugon G., Rivier F., Masmoudi A., Mercier J. and Mornet D. 2007 Modulation of p38 MAPK cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavengers administration in dystrophin-deficient mdx mice. Am. J. Pathol. 170, 633–643.